Donor CMV serologic status did not affect survival of either seronegative or seropositive recipients.

CMV-seropositive recipients had decreased survival, regardless of the donor's CMV serologic status. Cases were excluded from these curves if the CMV serologic status of either the recipient (n = 56) or the donor (n = 339) was unknown.